Hepatitis C

A Prospective, Multicenter, Observational Study on Compliance to Hepatitis C Treatments (CHEOBS): Characteristics of HCV-Infected Patients with Psychiatric Disorders
J Lang and others. Abstract 591.

The Safety and Efficacy of Viramidine Plus PegIFN alfa-2b Versus Ribavirin Plus PegIFN alfa-2b in Therapy-Naïve Patients Infected with HCV: Phase 3 Results (VISER1)
Y Benhamou and others. Abstract

Sustained Virologic Response (SVR) to Interferon alfa-2b +/- Ribavirin Therapy at 6 Months Reliably Predicts Long-term Clearance of HCV at 5-Year Follow Up
J McHutchison and others. Abstract 744.

Treatment Comparison of Patients with Chronic Hepatitis C and Elevated ALT vs Patients with Persistently Normal ALT: Preliminary Results of a Prospective Open Trial
W Vogel others. Abstract 615.

Peginterferon alfa-2b Therapy with and without Ribavirin in Patients with Thalassemia: A Randomized Study
S Kamal and others. Abstract 585.

Long-term, Low-dose Treatment with Pegylated Interferon alfa 2b Leads to a Significant Reduction in Fibrosis and Inflammatory Score in Chronic Hepatitis C Nonresponder Patients with Fibrosis or Cirrhosis
S Kaiser and others. Abstract 584.

Early Detection of Depressive Symptoms During Treatment With Pegylated Interferon a-2b and Ribavirin in Euthymic Chronic Hepatitis C Patients
P Goldstein and others. Abstract 5776.

More Rapid Drop of HCV RNA Level under Therapy and Better Sustained Response Rate in Egyptian Patients versus Non-Egyptian Patients with HCV Genotype 4
A El Ray and others. Abstract 571.

Hepatitis B

Final Analysis of Virological Outcomes and Resistance During 5 Years of Adefovir Dipivoxil Monotherapy in HBeAg-Negative Patients
K Borroto-Esoda and others. Abstract 483.

Safety and Efficacy of Adefovir Dipivoxil in Patients with Lamivudine- Resistant Chronic Hepatitis B Undergoing Liver Transplantation
E Schiff and others. Abstract 2.

Two-State Modeling of Virological and Biochemical Efficacy Plus Liver Biopsies Demonstrate Effi cacy of Adefovir Dipivoxil in HBeAg-Negative Chronic Hepatitis B over 4 or 5 Years
S Hadziyannis and others. Abstract 494.

The Improved Therapeutic Effects of Adefovir Dipivoxil in Patients with HBeAg-Negative Chronic Hepatitis B Offset Its Increased Cost Compared to Lamivudine
M Buti and others. Abstract 485.

Durability of HBeAg Seroconversion Following Adefovir Dipivoxil Treatment for Chronic Hepatitis B
TT Chang and others. Abstract 503.

HIV-HCV Coinfection

Effect of Peginterferon alfa-2b and Ribavirin on Histological Lesions in Patients with Hepatitis C Virus (HCV) and HCV/HIV Co-Infection: An Open-Label Trial